288 related articles for article (PubMed ID: 32754989)
1. Risk of Incident Type 2 Diabetes Mellitus Among Patients With Rheumatoid Arthritis: A Population-Based Cohort Study.
Jin Y; Chen SK; Liu J; Kim SC
Arthritis Care Res (Hoboken); 2020 Sep; 72(9):1248-1256. PubMed ID: 32754989
[TBL] [Abstract][Full Text] [Related]
2. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis.
Solomon DH; Love TJ; Canning C; Schneeweiss S
Ann Rheum Dis; 2010 Dec; 69(12):2114-7. PubMed ID: 20584807
[TBL] [Abstract][Full Text] [Related]
3. Risk of diabetes in patients with rheumatoid arthritis: a 12-year retrospective cohort study.
Su CC; Chen IeC; Young FN; Lian IeB
J Rheumatol; 2013 Sep; 40(9):1513-8. PubMed ID: 23818711
[TBL] [Abstract][Full Text] [Related]
4. Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study.
Dubreuil M; Rho YH; Man A; Zhu Y; Zhang Y; Love TJ; Ogdie A; Gelfand JM; Choi HK
Rheumatology (Oxford); 2014 Feb; 53(2):346-52. PubMed ID: 24185762
[TBL] [Abstract][Full Text] [Related]
5. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.
Ozen G; Pedro S; Holmqvist ME; Avery M; Wolfe F; Michaud K
Ann Rheum Dis; 2017 May; 76(5):848-854. PubMed ID: 27836820
[TBL] [Abstract][Full Text] [Related]
6. Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study.
Jafri K; Bartels CM; Shin D; Gelfand JM; Ogdie A
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):51-57. PubMed ID: 27696731
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study.
Meng H; Lam SH; So H; Tam LS
Semin Arthritis Rheum; 2024 Apr; 65():152416. PubMed ID: 38368730
[TBL] [Abstract][Full Text] [Related]
8. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
[TBL] [Abstract][Full Text] [Related]
9. Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases.
Sheahan A; Anjohrin S; Suruki R; Stark JL; Sloan VS
Clin Rheumatol; 2024 Jun; 43(6):1897-1907. PubMed ID: 38658403
[TBL] [Abstract][Full Text] [Related]
10. Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis.
Baker JF; England BR; George M; Cannon G; Sauer B; Ogdie A; Hamilton BC; Hunter C; Duryee MJ; Thiele G; Mikuls TR
Ann Rheum Dis; 2021 May; 80(5):566-572. PubMed ID: 33397733
[TBL] [Abstract][Full Text] [Related]
11. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
[TBL] [Abstract][Full Text] [Related]
12. Risk of incident diabetes in patients with gout: a cohort study.
Kim SC; Liu J; Solomon DH
Arthritis Rheumatol; 2015 Jan; 67(1):273-80. PubMed ID: 25332119
[TBL] [Abstract][Full Text] [Related]
13. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.
Ogdie A; Yu Y; Haynes K; Love TJ; Maliha S; Jiang Y; Troxel AB; Hennessy S; Kimmel SE; Margolis DJ; Choi H; Mehta NN; Gelfand JM
Ann Rheum Dis; 2015 Feb; 74(2):326-32. PubMed ID: 25351522
[TBL] [Abstract][Full Text] [Related]
14. Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway.
Kerola AM; Sexton J; Wibetoe G; Rollefstad S; Crowson CS; Mars N; Kazemi A; Haavardsholm EA; Kvien TK; Semb AG
Semin Arthritis Rheum; 2021 Oct; 51(5):1081-1088. PubMed ID: 34450506
[TBL] [Abstract][Full Text] [Related]
15. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.
Peters MJ; van Halm VP; Voskuyl AE; Smulders YM; Boers M; Lems WF; Visser M; Stehouwer CD; Dekker JM; Nijpels G; Heine R; Dijkmans BA; Nurmohamed MT
Arthritis Rheum; 2009 Nov; 61(11):1571-9. PubMed ID: 19877093
[TBL] [Abstract][Full Text] [Related]
16. Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.
Radner H; Lesperance T; Accortt NA; Solomon DH
Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1510-1518. PubMed ID: 27998029
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor α therapy.
Antohe JL; Bili A; Sartorius JA; Kirchner HL; Morris SJ; Dancea S; Wasko MC
Arthritis Care Res (Hoboken); 2012 Feb; 64(2):215-21. PubMed ID: 21972198
[TBL] [Abstract][Full Text] [Related]
18. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.
Solomon DH; Massarotti E; Garg R; Liu J; Canning C; Schneeweiss S
JAMA; 2011 Jun; 305(24):2525-31. PubMed ID: 21693740
[TBL] [Abstract][Full Text] [Related]
19. Treatment patterns and health care costs for patients with psoriatic arthritis on biologic therapy: a retrospective cohort study.
Zhu B; Edson-Heredia E; Gatz JL; Guo J; Shuler CL
Clin Ther; 2013 Sep; 35(9):1376-85. PubMed ID: 23954091
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity in psoriatic arthritis and rheumatoid arthritis.
Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
Intern Med J; 2018 Nov; 48(11):1360-1368. PubMed ID: 30047189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]